Trials / Withdrawn
WithdrawnNCT00375596
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
Study Withdrawn Prior to Determining Official Title
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of a new allergy medication
Detailed description
Study withdrawn prior to determining study details
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketotifen/vasoconstrictor |
Timeline
- First posted
- 2006-09-13
- Last updated
- 2015-02-20
Source: ClinicalTrials.gov record NCT00375596. Inclusion in this directory is not an endorsement.